PCM
ADMA icon

Potomac Capital Management’s ADMA Biologics ADMA Stock Holding History

Potomac Capital Management’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-120,000
Closed -$466K – 61
2022
Q4 		$466K Sell
120,000
-362,000
-75% -$1.12M 0.58% 46
2022
Q3 		$1.17M Sell
482,000
-47,300
-9% -$113K 1.47% 23
2022
Q2 		$1.05M Sell
529,300
-245,700
-32% -$483K 1.29% 25
2022
Q1 		$1.42M Hold
775,000
– – 1.36% 26
2021
Q4 		$1.09M Buy
+775,000
New +$1.02M 1.05% 29

Other funds holding ADMA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.83B AUM 190.64% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return